A research team from the University of Copenhagen has been successful in stopping invasive growth in a skin cancer model by utilising synthetic human skin.
Basal cell carcinoma and squamous cell carcinoma, jointly known as keratinocyte carcinoma and the most prevalent types of cancer diagnosed in the United States, are thought to be preventable with simple laser skin treatments, according to new research.
Experiments on mice and human cells reveal that the number of specialised immune cells ready to combat skin cancer increased when a novel therapy prevented their egress from melanoma tumours.
New research indicates that simple laser treatments to the skin may help to prevent the development of basal cell carcinoma and squamous cell carcinoma, which are collectively known as keratinocyte carcinoma and are the most common types of cancer diagnosed in the United States
Cancer treatment has transformed thanks to immunotherapy. The five-year survival rate for advanced melanoma, the deadliest type of skin cancer, has climbed from less than 10% to more than 50% since the development of immunotherapy in 2011. Sadly, immunotherapy only works on about half of mel
Immunotherapy has changed cancer treatment. Since the introduction of immunotherapy in 2011, the five-year survival rate in advanced melanoma, the most lethal form of skin cancer, has increased from less than 10% to more than 50%. Unfortunately, only approximately half of melanoma patients r
According to a recent study from the University of Gothenburg, the immunosuppressive medicine methotrexate (MTX) has been linked to an increased risk of three forms of skin cancer. Patients using the medicine have moderate to severe psoriasis; nonetheless, a risk increase for basal cell carc
New research indicates that simple laser treatments to the skin may help to prevent the development of basal cell carcinoma and squamous cell carcinoma, which are collectively known as keratinocyte carcinoma and are the most common types of cancer diagnosed in the United States.
Amyloid beta, a protein known to build up in the brains of Alzheimer's patients, also helps skin cancer cells thrive when they spread to the brain, a new study finds.